Objectives: To evaluate the medication adherence & non adherence in COPD patients.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a common chronic disease of the airways characterized by the gradual and progressive loss of lung function.
COPD is a disease state characterised by airflow limitation that is not fully reversible. The airflow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases [1] .
Global prevalence and burden of COPD:
The estimated global prevalence in adults aged 40 years and over is 9-10%.
Prevalence is projected to increase as a result of past high rates of tobacco use, and an ageing population. In addition to significant healthcare costs, COPD causes a significant reduction in health-related quality of life [2] .
Adherence is defined as "the extent to which a person's behaviour coincides with medical or health advice [3] . Adherence has been defined as the "active, voluntary, and collaborative involvement of the patient in a mutually acceptable course of behaviour to produce a therapeutic result". Morisky Medication Adherence Scale: were medium non adherent to medications. [11] António Duarte-de-Araújo, Pedro Teixeira, Venceslau Hespanhol, Jaime Correia-de-Sousa "COPD:
understanding patients' adherence to inhaled medications"
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